Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge

Diabetic nephropathy is the most common cause of end-stage renal disease worldwide. Control of blood glucose and blood pressure (BP) reduces the risk of developing this complication, but once diabetic nephropathy is established, it is then only possible to slow its progression. Sodium-glucose cotran...

Descripción completa

Detalles Bibliográficos
Autores principales: Provenzano, Michele, Pelle, Maria Chiara, Zaffina, Isabella, Tassone, Bruno, Pujia, Roberta, Ricchio, Marco, Serra, Raffaele, Sciacqua, Angela, Michael, Ashour, Andreucci, Michele, Arturi, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212983/
https://www.ncbi.nlm.nih.gov/pubmed/34150796
http://dx.doi.org/10.3389/fmed.2021.654557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212983/
https://www.ncbi.nlm.nih.gov/pubmed/34150796
http://dx.doi.org/10.3389/fmed.2021.654557

Ejemplares similares